Itron (NASDAQ:ITRI) Updates FY 2026 Earnings Guidance

Itron (NASDAQ:ITRI) issued an update on its FY 2026 earnings guidance on Tuesday morning. The company provided earnings per share (EPS) guidance of 6.300-6.500 for the period, compared to the consensus EPS estimate of 5.980. The company issued revenue guidance of $2.4 billion-$2.4 billion, compared to the consensus revenue estimate of $2.4 billion. Itron also updated its Q3 2026 guidance to 1.500-1.600 EPS.

Analyst Upgrades and Downgrades

ITRI has been the topic of several recent analyst reports. Stephens reissued an “overweight” rating and set a $130.00 target price on shares of Itron in a report on Wednesday, May 20th. Seaport Research Partners restated a “buy” rating on shares of Itron in a research report on Wednesday. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Itron in a research report on Friday, May 8th. Roth Capital reiterated a “buy” rating and issued a $136.00 target price on shares of Itron in a research note on Wednesday, April 29th. Finally, Oppenheimer upped their price target on Itron from $133.00 to $135.00 and gave the stock an “outperform” rating in a research note on Thursday, April 16th. Eight equities research analysts have rated the stock with a Buy rating, three have given a Hold rating and two have issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $131.33.

Itron Stock Performance

Shares of NASDAQ ITRI traded down $5.33 during mid-day trading on Wednesday, hitting $101.69. The company had a trading volume of 790,016 shares, compared to its average volume of 889,270. The business’s 50-day simple moving average is $83.62 and its 200-day simple moving average is $89.80. The company has a debt-to-equity ratio of 0.97, a current ratio of 2.66 and a quick ratio of 2.24. Itron has a 12 month low of $77.77 and a 12 month high of $142.00. The firm has a market cap of $4.51 billion, a P/E ratio of 16.20, a PEG ratio of 0.74 and a beta of 1.32.

Itron (NASDAQ:ITRI) last released its quarterly earnings data on Tuesday, July 28th. The scientific and technical instruments company reported $1.59 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.29 by $0.30. Itron had a return on equity of 19.54% and a net margin of 12.31%.The business had revenue of $562.90 million for the quarter, compared to analysts’ expectations of $566.34 million. During the same period in the previous year, the business posted $1.62 earnings per share. Itron’s quarterly revenue was down 7.2% on a year-over-year basis. Itron has set its Q3 2026 guidance at 1.500-1.600 EPS and its FY 2026 guidance at 6.300-6.500 EPS. As a group, analysts predict that Itron will post 6.01 earnings per share for the current fiscal year.

Insider Activity

In related news, CFO Joan S. Hooper sold 442 shares of the stock in a transaction that occurred on Tuesday, May 26th. The stock was sold at an average price of $84.37, for a total transaction of $37,291.54. Following the sale, the chief financial officer directly owned 117,478 shares in the company, valued at $9,911,618.86. This represents a 0.37% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, SVP Donald L. Reeves III sold 319 shares of the business’s stock in a transaction on Tuesday, May 26th. The stock was sold at an average price of $84.37, for a total value of $26,914.03. Following the completion of the transaction, the senior vice president directly owned 29,100 shares in the company, valued at approximately $2,455,167. This represents a 1.08% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last 90 days, insiders sold 3,946 shares of company stock worth $324,420. Insiders own 1.77% of the company’s stock.

Itron News Summary

Here are the key news stories impacting Itron this week:

• Positive Sentiment: Q2 earnings beat expectations: Itron reported non-GAAP diluted EPS of $1.59, exceeding the $1.29 consensus estimate. Adjusted EBITDA rose 8% to $97 million, while adjusted gross margin expanded to a record 41.4% from 36.9% a year earlier. Itron Announces Second Quarter 2026 Financial Results
• Positive Sentiment: Full-year earnings outlook raised: Itron now expects 2026 non-GAAP EPS of $6.30 to $6.50, above the prior consensus estimate of approximately $5.98. Management cited constructive demand related to grid expansion, resiliency and the need to accelerate power availability. Itron reports Q2 earnings and raises full-year 2026 EPS outlook
• Positive Sentiment: Recurring revenue and analyst support improved: Annual recurring revenue climbed 21% to $417 million, and Needham raised its price target from $116 to $128 while assigning a “Buy” rating. The target implies meaningful upside based on the reported reference price. Benzinga
• Neutral Sentiment: Third-quarter guidance was mixed: Itron projected EPS of $1.50 to $1.60, broadly in line with expectations, but revenue of $590 million to $600 million was below the roughly $607 million consensus estimate. Itron Q2 Revenue Falls 7 Percent to $563 Million
• Negative Sentiment: Revenue and GAAP profit declined: Second-quarter revenue fell 7% year over year to $563 million, below estimates, primarily because of lower Networked Solutions revenue. GAAP net income dropped to $53 million from $68 million, and free cash flow declined to $81 million from $91 million.

Institutional Trading of Itron

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Dimensional Fund Advisors LP lifted its stake in Itron by 18.1% in the fourth quarter. Dimensional Fund Advisors LP now owns 1,271,042 shares of the scientific and technical instruments company’s stock valued at $118,034,000 after acquiring an additional 194,768 shares during the last quarter. First Trust Advisors LP raised its stake in Itron by 4.1% in the fourth quarter. First Trust Advisors LP now owns 793,175 shares of the scientific and technical instruments company’s stock valued at $73,654,000 after buying an additional 31,088 shares during the period. Arrowstreet Capital Limited Partnership lifted its position in shares of Itron by 42.5% in the third quarter. Arrowstreet Capital Limited Partnership now owns 604,580 shares of the scientific and technical instruments company’s stock valued at $75,306,000 after buying an additional 180,366 shares during the last quarter. Schroder Investment Management Group boosted its stake in shares of Itron by 65.2% during the 4th quarter. Schroder Investment Management Group now owns 588,872 shares of the scientific and technical instruments company’s stock worth $54,683,000 after acquiring an additional 232,341 shares during the period. Finally, Millennium Management LLC raised its stake in Itron by 269.3% in the 4th quarter. Millennium Management LLC now owns 506,867 shares of the scientific and technical instruments company’s stock valued at $47,068,000 after acquiring an additional 369,617 shares during the period. 96.19% of the stock is owned by institutional investors.

About Itron

Itron, Inc (NASDAQ: ITRI) is a global technology company that develops innovative solutions to measure, manage and analyze the use of energy and water. Its comprehensive portfolio includes smart meters, data collection devices, communication networks and advanced software applications designed to optimize utility operations and foster sustainable resource management. The company’s offerings enable utilities and cities to accurately monitor consumption patterns, streamline billing processes and improve grid reliability.

Itron’s product lineup spans a range of hardware and software solutions, from residential and commercial smart meters to meter data management systems (MDMS), networked communication platforms and analytics tools.